Effect of caffeic acid phenethyl ester (CAPE) on vascular endothelial growth factor a (VEGF-A) gene expression in gentamicin-induced acute renal nephrotoxicity

dc.contributor.authorÇiğremiş, Yılmaz
dc.contributor.authorAkgöz, Müslüm
dc.contributor.authorÖzen, Hasan
dc.contributor.authorKaraca, Zeynal Mete
dc.date.accessioned2021-11-10T07:39:51Z
dc.date.available2021-11-10T07:39:51Z
dc.date.issued2018
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAbstract: Vascular endothelial growth factor-A (VEGF-A) gene expression in an experimental gentamicin-induced nephrotoxicity and ameliorative effect of caffeic acid phenethyl ester (CAPE) was investigated in rats. Animals were divided into four groups (n=8); control (C) group animals were given 10% dimethylsulfoxide (DMSO); gentamicin (G) group animals were given 100 mg/kg/day gentamicin; CAPE group animals were given 30 mg/kg/day CAPE and CAPE+G group animals were given 100 mg/kg/ day gentamicin plus 30 mg/kg/day CAPE. Serum creatinine and BUN levels significantly increased in gentamicin group as compared to the control group (p<0.05) while CAPE treatment did not significantly lower the levels of either BUN or creatinine (p>0.05). Gene expression level of VEGF-A in gentamicin group significantly decreased as compared to the control group, however, CAPE treatment did not have any increasing effect on the gene expression level. According to histopathological investigation, gentamicin treatment caused prominent degeneration in kidney tissue and CAPE treatment had only slight beneficial effect on lowering the tissue degeneration. The results showed that gentamicin decreases VEGF-A gene expression and this might be related to the tissue degeneration at cellular level. However, CAPE treatment did not have significant ameliorative effect in lowering the gentamicin induced nephrotoxicity.en_US
dc.identifier.citationKARACA Z. M,ÖZEN H,AKGÖZ M,ÇİĞREMİŞ Y (2018). Effect of caffeic acid phenethyl ester (CAPE) on vascular endothelial growth factor a (VEGF-A) gene expression in gentamicin-induced acute renal nephrotoxicity. Medicine Science, 7(4), 805 - 809. Doi: 10.5455/medscience.2018.07.8828en_US
dc.identifier.doi10.5455/medscience.2018.07.8828en_US
dc.identifier.endpage809en_US
dc.identifier.issn2147-0634
dc.identifier.issue4en_US
dc.identifier.startpage805en_US
dc.identifier.trdizinid307782en_US
dc.identifier.urihttps://doi.org/10.5455/medscience.2018.07.8828
dc.identifier.urihttps://hdl.handle.net/11616/43073
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/307782
dc.identifier.volume7en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofMedicine Scienceen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleEffect of caffeic acid phenethyl ester (CAPE) on vascular endothelial growth factor a (VEGF-A) gene expression in gentamicin-induced acute renal nephrotoxicityen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Öz.docx
Boyut:
18.59 KB
Biçim:
Microsoft Word XML
Açıklama:
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: